251 related articles for article (PubMed ID: 10195200)
21. Familial amyotrophic lateral sclerosis and Alzheimer's disease. Transgenic models.
Wong PC; Borchelt DR; Lee MK; Pardo CA; Thinakaran G; Martin LJ; Sisodia SS; Price DL
Adv Exp Med Biol; 1998; 446():145-59. PubMed ID: 10079842
[No Abstract] [Full Text] [Related]
22. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
[TBL] [Abstract][Full Text] [Related]
23. Bosentan preserves endothelial function in mice overexpressing APP.
Elesber AA; Bonetti PO; Woodrum JE; Zhu XY; Lerman LO; Younkin SG; Lerman A
Neurobiol Aging; 2006 Mar; 27(3):446-50. PubMed ID: 15894408
[TBL] [Abstract][Full Text] [Related]
24. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
25. Alterations in vascular reactivity in single- and double-transgenic mice coexpressing human APP-C100 and mutant SOD(1) genes.
Xue S; Li Q; Khalil Z
Chin Med J (Engl); 2002 May; 115(5):696-701. PubMed ID: 12133537
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer's disease model.
Ongali B; Nicolakakis N; Tong XK; Aboulkassim T; Papadopoulos P; Rosa-Neto P; Lecrux C; Imboden H; Hamel E
Neurobiol Dis; 2014 Aug; 68():126-36. PubMed ID: 24807206
[TBL] [Abstract][Full Text] [Related]
27. BACE overexpression alters the subcellular processing of APP and inhibits Abeta deposition in vivo.
Lee EB; Zhang B; Liu K; Greenbaum EA; Doms RW; Trojanowski JQ; Lee VM
J Cell Biol; 2005 Jan; 168(2):291-302. PubMed ID: 15642747
[TBL] [Abstract][Full Text] [Related]
28. Early regional cerebral glucose hypometabolism in transgenic mice overexpressing the V717F beta-amyloid precursor protein.
Dodart JC; Mathis C; Bales KR; Paul SM; Ungerer A
Neurosci Lett; 1999 Dec; 277(1):49-52. PubMed ID: 10643895
[TBL] [Abstract][Full Text] [Related]
29. Hypoxic stress, brain vascular system, and β-amyloid: a primary cell culture study.
Muche A; Bürger S; Arendt T; Schliebs R
Nutr Neurosci; 2015 Jan; 18(1):1-11. PubMed ID: 24257464
[TBL] [Abstract][Full Text] [Related]
30. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation.
Koistinaho M; Kettunen MI; Goldsteins G; Keinänen R; Salminen A; Ort M; Bures J; Liu D; Kauppinen RA; Higgins LS; Koistinaho J
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1610-5. PubMed ID: 11818564
[TBL] [Abstract][Full Text] [Related]
31. Superoxide and endothelium-dependent constriction to flow in porcine small pulmonary arteries.
Liu Q; Wiener CM; Flavahan NA
Br J Pharmacol; 1998 May; 124(2):331-6. PubMed ID: 9641550
[TBL] [Abstract][Full Text] [Related]
32. Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse.
Lehman EJ; Kulnane LS; Gao Y; Petriello MC; Pimpis KM; Younkin L; Dolios G; Wang R; Younkin SG; Lamb BT
Hum Mol Genet; 2003 Nov; 12(22):2949-56. PubMed ID: 14506131
[TBL] [Abstract][Full Text] [Related]
33. Endothelial nitric oxide: protector of a healthy mind.
Katusic ZS; Austin SA
Eur Heart J; 2014 Apr; 35(14):888-94. PubMed ID: 24357508
[TBL] [Abstract][Full Text] [Related]
34. Electrophysiological and cerebrovascular effects of the alpha-secretase-derived form of amyloid precursor protein in young and middle-aged rats.
Sánchez-Alavez M; Chan SL; Mattson MP; Criado JR
Brain Res; 2007 Feb; 1131(1):112-7. PubMed ID: 17157827
[TBL] [Abstract][Full Text] [Related]
35. Cerebrovascular endothelial dysfunction mediated by beta-amyloid.
Thomas T; McLendon C; Sutton ET; Thomas G
Neuroreport; 1997 Apr; 8(6):1387-91. PubMed ID: 9172141
[TBL] [Abstract][Full Text] [Related]
36. Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice.
Carlson GA; Borchelt DR; Dake A; Turner S; Danielson V; Coffin JD; Eckman C; Meiners J; Nilsen SP; Younkin SG; Hsiao KK
Hum Mol Genet; 1997 Oct; 6(11):1951-9. PubMed ID: 9302276
[TBL] [Abstract][Full Text] [Related]
37. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
[TBL] [Abstract][Full Text] [Related]
38. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
39. Impairment of amyloid precursor protein alpha-processing in cerebral microvessels of type 1 diabetic mice.
He T; Sun R; Santhanam AV; d'Uscio LV; Lu T; Katusic ZS
J Cereb Blood Flow Metab; 2019 Jun; 39(6):1085-1098. PubMed ID: 29251519
[TBL] [Abstract][Full Text] [Related]
40. Oxidized SOD1 alters proteasome activities in vitro and in the cortex of SOD1 overexpressing mice.
Le Pecheur M; Bourdon E; Paly E; Farout L; Friguet B; London J
FEBS Lett; 2005 Jul; 579(17):3613-8. PubMed ID: 15961078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
